We have developed a new, potent anticancer therapy with minimal side effects, as it has two levels of selectivity: a nanobody that directs a light-activatable drug to cancer cells, and light locally applied at the tumor to activate the drug.

Developing an innovative targeted immunotherapy against cancer using remote controlled conditional attenuated bacteria.

MaTiReX developed an advanced collagen plug to seal the fetoscopic entry points and solve the principal drawback of fetal surgery.

Matriarch 3DY Hydrogel, Matriarch Life Sciences not only addresses existing issues with the traditional hydrogels (such as Matrigel), but also provides the next level solution to the growing organoids market.

Diagnostic and treatment device for pelvic floor dysfunctions, such as prolapse, micturition, defecation and urinary and faecal incontinence

MedicalVR’s PulmoVR innovation enables thoracic surgeons to cure patients with lung cancer by preventing the unnecessary removal of healthy lung tissue, resulting in a ‘lung-sparing surgical procedure’ for lung cancer.

We firmly believe that everybody has the basic human right to live without the limitations of disease. Therefore, we aim to provide patients with new treatment options that add true value and allow them to break free from those limitations.

From Genes to Pathways to Novel Drugs For Multiple Sclerosis

Modular Therapeutics is revolutionizing how we understand and harness gene expression in medicine, moving beyond the static, linear models that have shaped the field for decades.